Product Description
The global hybrid operating room market was valued at $171.0 million in 2025. This is expected to increase over the forecast period at a CAGR of 9.3% to reach $317.8 million.
The full report suite on the global market for hybrid operating rooms (ORs) includes sales of a control system/hub/integration platform with extended imaging management capabilities.
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Hybrid Operating Room Market Trends

As procedural complexity continues to increase and healthcare providers seek greater efficiency and clinical precision, demand for hybrid ORs equipped with fixed advanced imaging systems has risen. Fixed imaging modalities such as angiography, computed tomography (CT) and magnetic resonance imaging (MRI) offer superior image quality, accuracy and consistency compared to mobile imaging, supporting high-acuity and image-guided procedures. These systems enable continuous, real-time visualization without the need to reposition patients, improving workflow efficiency and reducing procedural risk. Despite higher upfront costs, the clinical and operational advantages of fixed advanced imaging make it a key driver of investment in hybrid OR infrastructure.
Global Hybrid Operating Room Market Share Insights

- Getinge was the leading competitor in the global hybrid integration component market in 2025, gaining market share in recent years through partnerships with major imaging companies. The company has benefited from strong demand for its MAGNUS™ table, which is installed in a large share of hybrid ORs, allowing Getinge to leverage table placements alongside its integration component offerings. Its TEGRIS™ integration platform provides core integration capabilities, including video routing, streaming, conferencing and a workflow-oriented user interface, while the Maquet Yuno II™ OR table further supports hybrid OR adoption by offering procedural versatility and flexibility that appeals to hospitals upgrading to hybrid operating room environments.
- STERIS was the second-leading competitor in the global hybrid operating room market in 2025, building on its strong position in integrated ORs following the acquisition of Black Diamond Video in 2015. Under the Harmony Hybrid OR brand, the company offers integration systems that support 4K inputs and outputs across surgical displays and camera systems, with fiber-optic infrastructure designed for full 4K compatibility. Its integration components handle signal upscaling and conversion internally—eliminating reliance on monitor-side processing—while an all-in-one system approach enables cost efficiencies across multiple integration functions.
- KARL STORZ was the third-leading competitor in the hybrid operating room market in 2025. The company’s OR1™ NEO integrated OR solution is a well-established platform, while the OR1™ FUSION solution offers IP-based 4K video management technology. In addition to hardware, KARL STORZ provides modular, platform-independent software such as SCENARA™ for data management and administration, as well as AIDA™, an image and video storage system supporting HD, 4K, and 3D formats. In February 2023, KARL STORZ established KARL STORZ VentureONE, a subsidiary dedicated to robotic surgery solutions with locations in Singapore and Munich, and, in May 2022 announced the construction of two new production buildings in Germany.
Global Hybrid Operating Room Market Segmentation Summary
- Hybrid Operating Room Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.